Last update 07 Dec 2024

Human prothrombin complex (Guangdong Shuanglin)

Overview

Basic Info

Drug Type
Blood components
Synonyms-
Target
F10 x factor IX x factor VII x thrombin
Mechanism
F10 modulators(Coagulation factor X modulators), factor IX modulators(Coagulation factor IX modulators), factor VII modulators(Coagulation factor VII modulators)
Therapeutic Areas
Congenital DisordersHemic and Lymphatic DiseasesOther Diseases
Active Indication
Hemophilia B
Inactive Indication-
Originator Organization
Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
Active Organization
Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
CN (12 May 2023),
Hemophilia B
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Human prothrombin complex (Guangdong Shuanglin)
CTR20182080 / CompletedPhase 3
验证人凝血酶原复合物治疗乙型血友病的有效性及安全性的单臂、开放、多中心临床研究
[Translation] A single-arm, open, multicenter clinical study to verify the efficacy and safety of human prothrombin complex therapy in the treatment of hemophilia B
CTR20140124 / RecruitingPhase 3IIT
人凝血酶原复合物（PCC）治疗乙型血友病患者的安全性及疗效的多中心、开放性临床研究
[Translation] A multicenter, open-label clinical study on the safety and efficacy of human prothrombin complex (PCC) in the treatment of hemophilia B patients
100 Clinical Results associated with Human prothrombin complex (Guangdong Shuanglin)
Login to view more data
100 Translational Medicine associated with Human prothrombin complex (Guangdong Shuanglin)
Login to view more data
100 Patents (Medical) associated with Human prothrombin complex (Guangdong Shuanglin)
Login to view more data
100 Deals associated with Human prothrombin complex (Guangdong Shuanglin)
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Hemophilia B
CN
Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.Guangdong Shuanglin Biological Pharmaceutical Co. Ltd.
12 May 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free